Comparison of Vaginal Hyaluronic Acid Treatment Over Autologous Platelet Rich Plasma Treatment for Genitourinary Syndrome of Menopause

Status: Recruiting
Location: See location...
Intervention Type: Drug, Biological
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Genitourinary syndrome of menopause (GSM) is a collection of symptoms and signs caused by hypoestrogenic changes to the labia majora/minora, clitoris, vestibule/introitus, vagina, urethra, and bladder that occur in menopausal patients. Platelet-rich plasma is produced by collecting approximately 60-90 ml (4-6 tablespoons) of blood from the vein in patient's arm. The blood is spun using a centrifuge that separates the plasma and red blood cells. The treatment included vaginal estrogen supplement, vaginal hyaluronic acid supplement, vaginal laser, platelet-rich plasma, etc. The observational cohort study will be used for the study design. Questionnaires, pelvic examination, vaginal pap smear with maturation index (MI), vaginal pH, and other methods will be used to evaluate the effectiveness and side effects.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 45
Healthy Volunteers: t
View:

• Women with menopause

• Patients with symptoms of genitourinary syndrome of menopause

Locations
Other Locations
Turkey
Kanuni Sultan Suleyman Training and Research Hospital
RECRUITING
Istanbul
Contact Information
Primary
Ozan Karadeniz, MD
dr.ozankrdnz@gmail.com
+905333663003
Time Frame
Start Date: 2023-11-01
Estimated Completion Date: 2024-12-01
Participants
Target number of participants: 60
Treatments
Experimental: Menopause patients having genitourinary syndrome (PRP)
Preparation of PRP sample from the patient's own blood and then the volume immediately above the erythrocyte layer was collected. Calcium gluconate in conc. 1:9 will be used as an activator. After activation, in a period of less than 2 min, approximately 4 ml of the PRP will be injected into the vaginal wall. ( at 3,6 and 9 o clock)It will be repeated once a month for 3 times.
Active_comparator: vaginal hyluronic acid supplement for GSM
Patients receive Vaginal Hyaluronic Acid supplement for 10 days, then once a week for 3 months.
Related Therapeutic Areas
Sponsors
Leads: Kanuni Sultan Suleyman Training and Research Hospital

This content was sourced from clinicaltrials.gov